Cargando…

Advances in hepatitis B therapeutics

Despite the availability of both effective preventive vaccines and oral antivirals, over 250 million people are chronically infected with the hepatitis B virus (HBV). Globally, chronic hepatitis B is the leading cause of hepatocellular carcinoma, which represents the third cause of cancer mortality,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soriano, Vicente, Barreiro, Pablo, Cachay, Edward, Kottilil, Shyamasundaran, Fernandez-Montero, José V., de Mendoza, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570774/ https://www.ncbi.nlm.nih.gov/pubmed/33117536 http://dx.doi.org/10.1177/2049936120965027

Ejemplares similares

Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era
por: Mathur, Poonam, et al.
Publicado: (2018)

Coronavirus and other airborne agents with pandemic potential
por: Fernandez-Montero, Jose Vicente, et al.
Publicado: (2020)

Reconstitution of T follicular helper-humoral immune axis with elimination of hepatitis C virus
por: Khanam, Arshi, et al.
Publicado: (2020)

AIDS Clinical Research in Spain—Large HIV Population, Geniality of Doctors, and Missing Opportunities
por: Soriano, Vicente, et al.
Publicado: (2018)

A Phase 2 open label study of ledipasvir/sofosbuvir for 12 weeks in subjects with hepatitis B virus infection
por: Price, Angie S., et al.
Publicado: (2022)

Immunomodulatory therapies for COVID-19
por: Mathur, Poonam, et al.
Publicado: (2022)

Eight Weeks of Ledipasvir/Sofosbuvir in Kidney Transplant Recipients With Hepatitis C Genotype 1 Infection
por: Husson, Jennifer S., et al.
Publicado: (2017)

Use of antibiotics in respiratory viral infections
por: Fernández-Montero, José Vicente, et al.
Publicado: (2022)

Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis
por: Mattingly, T. Joseph, et al.
Publicado: (2019)

Long-term treatment of patients with HIV-1: the role of atazanavir
por: Artacho, Miguel Ángel, et al.
Publicado: (2010)

Need to Face Liver Cirrhosis after HCV Cure with Antivirals
por: Soriano, Vicente, et al.
Publicado: (2017)

Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus
por: Cachay, Edward R, et al.
Publicado: (2019)

Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy
por: Soriano, Vicente, et al.
Publicado: (2023)

Screening for retroviruses and hepatitis viruses using dried blood spots reveals a high prevalence of occult hepatitis B in Ghana
por: de Mendoza, Carmen, et al.
Publicado: (2019)

Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression
por: Khanam, Arshi, et al.
Publicado: (2021)

Third wave of COVID-19 in Madrid, Spain
por: Soriano, Vicente, et al.
Publicado: (2021)

Hepatitis C Treatment Outcomes in Persons With HIV and Decompensated Cirrhosis Using a Collaborative Multidisciplinary HIV-Centered Approach
por: Cachay, Edward R., et al.
Publicado: (2021)

Durable Sustained Virologic Response After Oral Directly Acting Antiviral Therapy Despite Immunosuppressive Treatment
por: Hahn, Katherine J., et al.
Publicado: (2015)

Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in Spain
por: Barandalla, Ignacio, et al.
Publicado: (2021)

Transcriptional profiling of PBMCs unravels B cell mediated immunopathogenic imprints of HCV vasculitis
por: Comstock, Emily, et al.
Publicado: (2017)

Systemic manifestations of hepatitis C infection
por: Tang, Lydia, et al.
Publicado: (2016)

Ultra-long-acting (XLA) antivirals for chronic viral hepatitis
por: Soriano, Vicente, et al.
Publicado: (2022)

Why such excess of mortality for COVID-19 in Spain?
por: Soriano, Vicente, et al.
Publicado: (2020)

New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter?
por: Khanam, Arshi, et al.
Publicado: (2022)

Potential Use of Adjuvant Bacteriophage Therapy With Debridement, Antibiotics, and Implant Retention Surgery to Treat Chronic Prosthetic Joint Infections
por: Doub, James B, et al.
Publicado: (2021)

Main differences between the first and second waves of COVID-19 in Madrid, Spain
por: Soriano, Vicente, et al.
Publicado: (2021)

Abnormal brain diffusivity in participants with persistent neuropsychiatric symptoms after COVID-19
por: Liang, Huajun, et al.
Publicado: (2023)

Tickling the TLR7 to cure viral hepatitis
por: Funk, Emily, et al.
Publicado: (2014)

Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
por: Khanam, Arshi, et al.
Publicado: (2021)

Advances in Immunotherapy for Hepatitis B
por: Wang, Dongyao, et al.
Publicado: (2022)

Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways
por: Khanam, Arshi, et al.
Publicado: (2023)

1057. CpG-adjuvanted Hepatitis B vaccination improves seroprotection rates in Veterans with HIV
por: Deming, Meagan, et al.
Publicado: (2020)

No impact of IL28B polymorphisms on liver enzymes in patients coinfected with HIV and HCV
por: Fernández-Montero, JV, et al.
Publicado: (2010)

Lymphocyte Landscape after Chronic Hepatitis C Virus (HCV) Cure: The New Normal
por: Ghosh, Alip, et al.
Publicado: (2020)

Recent Advances in Hepatitis B Treatment
por: Prifti, Georgia-Myrto, et al.
Publicado: (2021)

Advances in treatment and prevention of hepatitis B
por: Shah, Niraj James, et al.
Publicado: (2021)

Type I interferons and TGF-β cooperate to induce liver fibrosis during HIV-1 infection under antiretroviral therapy
por: Ahodantin, James, et al.
Publicado: (2022)

Therapeutic vaccination for treatment of chronic hepatitis B
por: Cargill, Tamsin, et al.
Publicado: (2021)

Novel therapeutic strategies for chronic hepatitis B
por: Phillips, Sandra, et al.
Publicado: (2022)

158 Hepatitis C Treatment Update: Current Status and Future Direcctions
por: Kottilil, Shyam
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_icq49oshkiuuvhhuleaf0g6sgc